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Summary 
The thymic lesion of the nude mouse causes a profound block in T cell development. The failure 
of most T  cells to mature in nude mice is likely to reflect a requirement for signals elaborated 
in the normal thymus. Interleukin 7 (I1:7), a lymphokine that is normally expressed in the thymus 
and has been implicated in T cell maturation, might be central to this process. To test this possi- 
bility, we introduced a transgene directing lymphoid expression of I1:7 into nude mice and found 
that it substantially alleviates the block in T cell maturation caused by the thymic defect. I1:7 
transgenic nude mice have increased numbers of peripheral cells expressing the T  cell marker 
Thy-1, the T cell antigen receptor complex, and the co-receptors CD4 and CD8. The I1:7 trans- 
gene also restores T cell-specific proliferation and activation responses to the peripheral cells of 
transgene-rescued nude mice. Such findings point toward a fundamental role for I1:7 in the thymic 
maturation of T  cells. 
N 
'ude  mice are widely used  as  a  model of immuno- 
deficiency. The autosomal recessive nude mutation in- 
terferes with hair formation and prevents the normal devel- 
opment of the thymus. The thymic defect caused by the nude 
mutation results in a nearly complete block in T  cell devel- 
opment (1). T cell maturation in nude mice can be restored 
by thymic epithelial tissue grafts (2). Thus, the failure of most 
T cell precursors to mature in nude mice is due to their lack 
of exposure to the normal thymic microenvironment (3). 
In passing through the normal thymus, the population of 
T cell progenitors undergoes a highly selective process of refine- 
ment of the large array of TCR generated by somatic rear- 
rangement of their genes. This process involves the progres- 
sion through three distinct  developmental stages  that  are 
characterized by the expression of the co-receptors CD4 and 
CD8.  Bone marrow-derived T  cell progenitors enter the 
thymus with germline configuration TCR genes and lack 
expression of TCR, CD3, CD4, or CD8 (CD4-CD8-).  As 
the cells rearrange and express  their TCR genes, they also 
begin to express both CD4 and CD8 (CD4+CD8§  Cells 
expressing TCR that interact with self MHC in conjunction 
with CD4 or CD8,  are stimulated to proliferate, turn off 
either CD4  or CD8,  and migrate from the cortex to the 
medulla and then to the periphery as mature CD4 +  CD8- 
or CD4-CD8 + T cells (positive  selection).  Cells expressing 
TCR that react with self peptides complexed with MHC 
molecules are stimulated to die (negative selection).  Less than 
5%  of TCR pass these two tests and persist in the refined 
repertoire of TCR expressed by the T  cells that emerge to 
the periphery (4,  5). 
The  signals  that  normally  support  this  developmental 
progression in the thymus are not thoroughly characterized. 
However, in the absence of normal thymic tissue the progres- 
sion is almost entirely blocked. Lacking normal thymic tissue, 
nude mice fail to develop mature T cells and are profoundly 
immunodeficient. Only a very small population of T  cells 
that increases  with age is detected in older nude mice (6). 
These may be a subset of T cells that do not require exposure 
to thymic tissue to mature (7) or, conversely, nude mice may 
have some residual function in their defective thymic vestige 
or in nonthymic tissue that mimics the normal thymic an- 
lage and allows some T  cells to mature. Some of these few 
T cells in nude mice may arise via positive selection (8), how- 
ever, they appear to escape  negative selection (9,  10). 
I1:7 conveys proliferative signals to B and T cell progen- 
itors (11-16) and activating signals to mature T cells (17, 18). 
Several observations suggest a role for this lymphokine in 
T cell maturation in the thymus. I1:7 is expressed in murine 
adult (11) and fetal (19,  20)  thymus as well as in cultured 
thymic epithelial cells (14, 21, 22). The treatment of imma- 
ture CD4-CDS-  thymocytes with I1:7 in vitro stimulates 
their proliferation and preserves their ability to reconstitute 
lymphocyte-depleted  thymic organ culture (23). I1:7 also sup- 
ports rearrangement and expression of TCR genes in cul- 
tured thymocytes (24-27) and administration of IL-7 to normal 
or lymphopenic mice results in increased numbers of periph- 
eral B and T  cells (28,  29).  On the other hand,  anti-IL-7 
antibodies inhibit growth of fetal thymocytes in organ cul- 
ture (19) and anti-I1:7 or anti-I1:7-receptor antibodies de- 
plete thymocytes in adults (30, 31). Moreover, T cell matura- 
tion in I1:7 receptor-deficient mice is sharply curtailed and 
these mice have very few thymocytes or mature T cells (32). 
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CD3  --~ Nude mice with intrasplenic transplants of thymic epithelial 
cell lines that express II.7 (21), or subcutaneous implants of 
encapsulated fetal thymic tissue (33), exhibit enhanced T cell 
maturation.  In the latter case, this maturation is partially in- 
hibited by anti-Ib7  antibodies. 
In light of these observations we investigated the role of 
IL-7 in T  cell maturation  in vivo by examining  the effects 
of transgenic expression of I1.7 in lymphocytes of nude mice. 
If exposure to Ib7 in the thymus is a critical event in T cell 
maturation, then lymphocytes that express I1.7 might be able 
to mature without  encountering  normal  thymic epithelia. 
To test this hypothesis, we made use of a transgenic mouse 
strain (TG.UP) that carries an IL-7 transgene expressed under 
the control of immunoglobulin heavy chain gene promoter 
and enhancer  sequences (34).  Lymphoid expression of I1.7 
by this transgene,  or an engineered retrovirus  (35) reduces 
the  size  of the  intermediate  CD4+CD8 +  population  of 
thymocytes, possibly reflecting accelerated maturation  and 
exit of thymocytes. In older mice, this transgene also causes 
a population of CD4-CDS-  T cells to arise in the skin and 
later induces the stochastic development of lymphomas. 
Materials and Methods 
Animals.  FVB/N mice carrying the TG.UP Ib7 transgene (34) 
were bred with Swiss or BALB/c nude mice (Taconic Farms Inc., 
Germantown, NY) and F2 animals were analyzed. All animals were 
housed under specific  pathogen-flee conditions. Homozygous nude 
animals were identified by phenotype and heterozygous transgenic 
animals were identified by hybridization with DNA prepared from 
tail biopsy. 
Flow Cytometry. Spleen cells were prepared from age matched 
animals (60-100 d) of each of the four genotypes  of F2 animals 
(wild type, II.-7 transgenic, nude, and nude IL-7 transgenic), stained 
with fluorescent-labeled antibodies and subjected to flow cytom- 
etry in a Cytofluorograf II flow cytometry machine (Becton Dick- 
inson & Co., Mountain  View, CA).  Dead cells were eliminated 
from the analyses  by gating with forward and perpendicular scatter. 
Data were analyzed with software from Ortho Diagnostics Systems 
Inc. (Raritan,  NJ) and Cytomation (Fort Collins,  CO). 
Antibodies.  The following antibodies were used in this study: 
monoclonal rat anti-mouse CD3 29B (36), monoclonal hamster 
anti-mouse CD3 145.2Cll (37), FITC-conjugated polyclonal goat 
anti-rat-immunoglobulin  antibodies (FITC-anti-rat Ig) (Kirkegaard 
& Perry Laboratories, Gaithersburg, MD), FITC-anti-Thy-l.1, FITC- 
anti-Thy-l.2 (New England  Nuclear, Boston, MA) and PE-anti- 
B220 (CD451L), PE-anti-CD4,  PE-anti-CD8 and FITC-anti-CD3 
(PharMingen, San Diego, CA), FITC-anti-CD8 and PE-anti-CD4 
(Becton Dickinson  & Co.). 
Proliferation Assays.  Triplicate microwell cultures of spleen cells 
(1-5  x  l0  s cells in 0.1 ml) were incubated at 37  ~ in 7% C02 and 
100% humidity for 2 d in RPMI 1640 medium (Sigma Chemical 
Co., St. Louis, MO) supplemented with 10% bovine calf serum, 
2 mM glutamine, 50 U/ml penicillin, 50 #g/ml streptomycin and 
50/~M 2-ME in the presence or absence of plate-bound anti-CD3 
mAb 145.2Cll  (plates were coated with mAb at  1.4 ~g/ml in 
H20 for 60 rain at 37  ~  or 2.5/~g/ml Con A (Sigma Chemical 
Co.). Cultures were labeled with 1 #Ci/well [3H]thymidine (New 
England Nuclear) overnight, lysed by osmotic shock, and faltered 
through glass fiber filters in an automated cell harvester. Filter-bound 
[3H]thymidine was measured by scintillation counting. 
IL,2 Synthesis Assa2/s.  Relative II--2 production  was measured 
with the IL-2-dependent cell line, HT2 (38). Portions of superna- 
tants from unlabeled cultures of spleen cells as described above  were 
removed after 2 d and added to cultures of HT2 cells. Growth of 
the HT2 cells was then measured by |3H]thymidine incorporation 
as described above for the spleen cells. 
Results and Discussion 
The Ib7 transgene was introduced into homozygous nude 
mice by conventional mating. On analysis, it was indeed found 
that of 20 nude mice carrying the II,7 transgene examined, 
18 exhibited partially restored T cell populations. For example, 
roughly half of the spleen cells derived from wild-type mice 
and somewhat fewer of the cells derived from euthymic II:7 
transgenic mice express CD3, whereas spleen cells from age- 
matched nude mice are largely devoid of CD3  (Fig.  1 A). 
In contrast,  the nude IL-7 transgenic  spleen cells contain a 
prominent population of CD3 + cells (Fig.  1 A). This popu- 
lation  is  smaller  than  the CD3 + population  of wild-type 
mice, but it is comparable to that  of 11"7 transgenic mice. 
Similarly,  a comparison of the B cell-specific B220 (CD45R) 
and T  cell-specific  Thy-1  antigens  reveals  a population  of 
Thy-l*B220-  T  cells  that  is almost  completely absent in 
nude mice and restored in the nude I1"7 transgenic mice (Fig. 
1 B). In addition to the CD3/TCR. complex and Thy-1, these 
cells also express the co-receptors CD4 or CD8 (Fig.  1 C). 
Prominent  populations  of CD4+CD8 -  and CD4-CD8 + 
(single positive) cells are observed among nude I1"7 trans- 
genie spleen cells in a pattern  similar  to those seen in eu- 
thymic animals  and absent in nontransgenic  nude animals 
(Fig.  1 C).  A  small number (2%) of nude II.-7 transgenic 
spleen cells appear to express both CD4 and CD8. These cells 
are not detected in euthymic mice.  It is possible that  they 
represent an intermediate population of T cell precursors that 
Figure  1.  Immunofluorescent  flow cytometry  of T cell surface  markers. (A) CD3 expression of spleen calls. Cells were stained with anti-CD3 29B 
and FITC-anti-rat Ig and analyzed. The relative fluorescence  intensity (x ax/s) of dissociated spleen cells from mice of the indicated genotypes  is plotted 
against their frequency ~ axis). The entire x axis range represents 3.2 logt0 units. (B) Expression of B220 and Thy-1 on spleen cells. Cells stained 
with PITC-anti-Thy-l.1, FITC-anti-Thy-l.2 and PE-anti-B220 were analyzed as above. Relative  levels of B220 0' axis) and Thy-1 (x ax/s) expression are 
indicated by the positions of the spots (log scale). Percentages of the cells in each quadrant are noted in the outside comers of each box. (C) Expression 
of CD4 and CD8 on spleen cells. Calls stained with FITC-anti-CD8 and PE-anti-CD4 antibodies were analyzed and represented as above. (/9) Expres- 
sion of CD4 or CD8 and CD3 on spleen cells. Cells stained with PE-anti-CD4, PE-anti-CD8, and FITC-anti-CD3 mAbs were analyzed and represented 
as above. 
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extent the CD4 +CDS-  or CD4-CD8 + cells  also  express 
CD3, we utilized a mixture of anti-CD4 and anti-CD8 mAbs 
and anti-CD3 mAb to define this population (Fig. 1 D). While 
the nude mice had very few cells expressing CD3 and almost 
none of these express  CD4 or CDS,  most CD3 + cells de- 
rived from the wild type, II.,7 transgenic, and nude Ib7 trans- 
genic mice do express CD4 or CD8. No significant popula- 
tions of CD4 + or CD8 + cells lacking CD3 were detected. 
Since we observed cells expressing T  cell surface markers 
in nude I1:7 transgenic mice, we sought to determine whether 
they were able to function as T cells. We tested this by meas- 
uring their abilities to respond to activation of the TCK com- 
plex in vitro (Fig.  2). Spleen cells from mice of each of the 
four genotypes were cultured in the presence or absence of 
immobilized anti-CD3 mAb or Con A. The cultures were 
evaluated for proliferation and for production of IL-2. While 
cells from euthymic mice responded vigorously to TCR stim- 
ulation by proliferating and secreting Ib2 regardless of the 
presence of the IL-7 transgene, cells from nontransgenic nude 
mice had minimal responses. Spleen cells from Ib 7 transgenic 
nude mice, however, responded at  nearly wild-type levels. 
Thus nude mice expressing IL-7 under the control of im- 
munoglobulin regulatory sequences develop significant num- 
bers of peripheral T cells. These T cells are similar in pheno- 
type to those of wild-type mice in that they express Thy-1, 
CD4 or CD8 and the TCK complex. Moreover, when the 
TCR complex is engaged, these T  cells respond by prolifer- 
ating and secreting I1:2 in a similar fashion to wild-type T cells. 
While it appears that the T cells found in I1:7 transgenic 
nude mice arise from increased maturation of T cell precursors 
that are otherwise blocked in nontransgenic nude mice, the 
data in this study do not rule out the possibility that these 
T cells represent an expansion of the few T cells that are present 
in nontransgenic nude mice. Since II:7 has been shown to 
stimulate both maturation and proliferation of T lineage cells 
in various assays, both of these phenomena may contribute 
to the formation of T  cell populations in nude I1:7  trans- 
genic mice. 
Transgenic expression of IL-7 in these mice may replace 
the exposure to II.,7 that T cell precursors normally encounter 
in the thymus and thus facilitate their maturation in the ab- 
sence of this  organ.  Indeed, in  the recent analysis  of I1:7 
receptor-deficient mice it was found that  the numbers of 
thymocytes in those mice are sharply reduced and matura- 
tion is variably impeded (32). This demonstrates that signals 
transmitted via the I1:7 receptor are critical for the develop- 
ment of T  cells in the thymus. 
Previous work of ours and others has described perturba- 
tions in the profile of maturing thymocytes  induced by deregu- 
lated expression of IIr  in the thymus (34, 35). As noted above, 
the depletion of the CD4+CD8 + population induced by the 
II.-7 transgene in euthymic mice may be due to accelerated 
maturation to CD4+CD8 -  or CD4-CD8 + cells and exit 
to the periphery. The present findings are consistent with 
this model and imply that  I1:7  signaling may act at both 
the CD4-CD8-  to CD4+CD8 + and the CD4+CD8 + to 
CD4 +  CD8-  or CD4- CD8 + transitions. 
The molecular basis of the nude mutation has recently  been 
identified as a single base pair deletion in the third exon of 
a novel gene, whn, that encodes a protein related to the winged- 
helix domain family of transcription factors (39). Expression 
of this gene is detected exclusively in the thymus and skin. 
However, it is unlikely that the whn protein interacts directly 
with the I1:7  gene. Although I1:7  is expressed in thymus 
and skin (40) it is also expressed in kidney, spleen, and bone 
marrow (11). Furthermore, B cell populations appear largely 
intact in nude mice, indicating that bone marrow expression 
Figure 2.  Functional analysis 
of splenic T cells. (,4) [3H]thymi- 
dine incorporation by spleen cells 
in vitro.  Cells were cultured  in 
medium alone, (white),  medium 
plus plate-bound anti-CD3 mAb 
145.2Cll (shaded) or medium plus 
2.5 ~g/ml Con A (blacb), Incor- 
porated [3H]tbymidine was mea- 
sured by scintillation  counting. 
Means and standard deviations of 
measurements  from representative 
triplicate cultures of cells  from the 
indicated genotypes are plotted. 
(B) Ib2 production by spleen  cells 
in vitro. Relative Ib2 production 
was  measured  with  the  11:2- 
dependent  cell line,  HT2  (38). 
Supernatants  from  unlabeled 
cultures  as  in  Fig.  2  A  were 
added to  cultures  of HT2  cells 
and their growth was measured 
by [3H]thymidine  incorporation 
as in Fig. 2 A. 
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whn protein. It is more likely that certain cell lineages within 
the skin and thymus that express Ib7 are dependent on whn. 
The restoration of significant populations of T cells in nude 
mice points toward a central role for Ib7 in thymic matura- 
tion of T cells. While it is unlikely that the function of the 
thymus in generating immunity can be entirely replaced by 
a single molecule, our results suggest that I1,-7 might be an 
agent useful in the treatment of immunodeficient states. 
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